Peter M. Hecht - May 6, 2021 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Chief Executive Officer, Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Stock symbol
CYCN
Transactions as of
May 6, 2021
Transactions value $
$733,860
Form type
4
Date filed
5/10/2021, 08:45 AM
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCN Common Stock Purchase $734K +302K +32.74% $2.43 1.22M May 6, 2021 Direct F1
holding CYCN Common Stock 485 May 6, 2021 The 2000 Trust for Alexis Mae Hecht F2
holding CYCN Common Stock 485 May 6, 2021 The 2000 Trust for Malcolm Paul Hecht F2
holding CYCN Common Stock 485 May 6, 2021 The 2000 Trust for Zoe Niovi Hecht F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.59, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
F2 These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.